---
figid: PMC9096358__atm-10-08-478-f6
pmcid: PMC9096358
image_filename: atm-10-08-478-f6.jpg
figure_link: /pmc/articles/PMC9096358/figure/f6/
number: Figure 6
figure_title: ''
caption: CB restrained the proliferation of cancer cells in vitro. (A,B) Effects of
  CB on the proliferation of HT-29 cells (A) and CT26 cells (B). (C,D) Effects of
  NaB on the proliferation of HT-29 cells (C) and CT26 cells (D). (E,F) Effects of
  CB supernatant on the proliferation of HT-29 cells (E) and CT26 cells (F). Error
  bars represent mean ± SD; **P<0.01. Ctrl, control group; MOI, multiplicity of infection;
  BHI, Brain Heart Infusion Medium; CB, Clostridium butyricum.
article_title: Clostridium butyricum inhibits the progression of colorectal cancer
  and alleviates intestinal inflammation via the myeloid differentiation factor 88
  (MyD88)-nuclear factor-kappa B (NF-κB) signaling pathway.
citation: Mingyao Zhou, et al. Ann Transl Med. 2022 Apr;10(8):478.
year: '2022'

doi: 10.21037/atm-22-1670
journal_title: Annals of Translational Medicine
journal_nlm_ta: Ann Transl Med
publisher_name: AME Publishing Company

keywords:
- Clostridium butyricum (CB)
- colorectal cancer (CRC)
- gut microbiota
- myeloid differentiation factor 88 (MyD88)
- nuclear factor-kappa B/p65 (NF-κB/p65)

---
